View Complaint
Retainer Agreement
info@rosenlegal.com

Emergent BioSolutions shareholders have an opportunity to recover their investment losses.

Click "Join this Class Action" above.

Attorneys

Emergent BioSolutions, Inc.

Rosen Law Firm announces the filing of a class action lawsuit on behalf of purchasers of Emergent BioSolutions, Inc. securities (NYSE: EBS) from January 11, 2016 through June 21, 2016, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Emergent BioSolutions investors under the federal securities laws.

If you purchased shares of Emergent BioSolutions from January 11, 2016 through June 21, 2016, and would like to join the action, please click "Join This Class Action" above.

Press Release

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Emergent BioSolutions, Inc. - EBS

New York, N.Y., July 20, 2016.  Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Emergent BioSolutions, Inc. common stock (NYSE: EBS) from January 11, 2016 through June 21, 2016, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Emergent BioSolutions investors under the federal securities laws.

To join the Emergent BioSolutions class action, go to the firm’s website at http://rosenlegal.com/cases-922.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for more information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, throughout the Class Period defendants issued false and misleading statements relating to future lucrative contract renewals and demand from the U.S. government for its anthrax vaccine BioThrax. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 19, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm’s website at http://rosenlegal.com/cases-922.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

-------------------------------

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      Kevin Chan, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 34th Floor
      New York, NY  10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      lrosen@rosenlegal.com
      pkim@rosenlegal.com
      kchan@rosenlegal.com
      www.rosenlegal.com